In this fireside chat, Maria Lamottke talks to Christoph Eicken and focuses on the aspects of cybersecurity for biotech and pharmaceutical companies.
Are there any special considerations when it comes to biotech and cybersecurity? Who is responsible for establishing and implementing a cybersecurity strategy? What are cost factors? Do you really need to worry about it unless you work in the defense industrial base? Why do investors start to pay attention to cybersecurity?
Find your weak point and avoid the next attack.
Listen to it on YouTube https://www.youtube.com/watch?v=FRLTvvo0pco
Comment here or connect via pr@bicoll-group.com and bio@ecuron.com.
The current white paper is available at https://www.ecuron.com/publications